SOLIGENIX, INC. (NASDAQ:SNGX) filed a Form 8-K with the Securities and Exchange Commission on January 23, 2026, disclosing a material event.
SOLIGENIX, INC.'s stock currently trades at $1.38 with a market capitalization of $16.4M. The Healthcare company's stock moved following the disclosure.